Echo Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Echo Therapeutics is developing and marketing.
Echo Therapeutics doesn't have any recent trademark applications, indicating Echo Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
AZONE Pharmaceutical preparations, namely, topical creams, gels, lotions, and sprays for the medical and therapeutic treatment of skin disorders
12/31/2012
E transdermal continuous glucose monitoring system consisting of a mechanical skin ablator, a biosensor, a hydrogel, and a transceiver with wireless connectivity capabilities; mechanical skin ablator for medical and cosmeceutical purposes
06/14/2011
AZONE TS Chemicals, namely, penetration enhancers for use with chemical, diagnostic, cosmetic, therapeutic, and fungicidal agents
11/09/2010
See all trademarks and details in the Full Report.
Market Share of Echo Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Echo Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Echo Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Echo Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.